Biomed Central Ltd

SHERPA: Unknown

People

  1. Postow
    Postow
  2. D'Angelo
    D'Angelo
  3. Offit
    Offit
  4. Budhu
    Budhu
  5. Motzer
    Motzer
  6. Shoushtari
    Shoushtari
  7. Voss
    Voss
  8. O'Reilly
    O'Reilly
  9. Robson
    Robson
  10. Autio
    Autio

Groups

  1. Department of Medicine (461)
  2. Solid Tumor Oncology Division (461)
  3. GSK Faculty (161)
  4. Melanoma and Immunotherapeutics Service (148)
  5. Hematologic Malignancies, Division of (99)
  6. Hematology-Oncology Fellows (85)
  7. Genitourinary Oncology Service (81)
  8. Melanoma Disease Management Team (78)
  9. Sloan Kettering Institute Postdocs (76)
  10. Weinberg Fellows (70)
Search Within
  1. "Solid Tumor Oncology Division"
Formats
  1. Journal Article (220)
  2. Meeting Abstract (210)
  3. Guidelines (12)
  4. Review (9)
  5. Editorial (7)
  6. Correspondence (1)
  7. Miscellaneous (1)
  8. Research Letter (1)
Groups
  1. Department of Medicine (461)
  2. Solid Tumor Oncology Division (461)
  3. GSK Faculty (161)
  4. Melanoma and Immunotherapeutics Service (148)
  5. Hematologic Malignancies, Division of (99)
  6. Hematology-Oncology Fellows (85)

More Groups

People
  1. Jedd Wolchok (83)
  2. Taha Merghoub (55)
  3. Michael Postow (43)
  4. Matthew Hellmann (30)
  5. Sandra D'Angelo (26)
  6. Kenneth Offit (23)

More People

Years
  1. 2025 (12)
  2. 2024 (23)
  3. 2023 (20)
  4. 2022 (74)
  5. 2021 (58)
  6. 2020 (60)

More Years

Publications
  1. Journal for ImmunoTherapy of Cancer (322)
  2. Breast Cancer Research (32)
  3. BMC Cancer (25)
  4. Journal of Translational Medicine (23)
  5. Genome Medicine (9)
  6. Journal of Hematology & Oncology (8)

More Publications

Results (461)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II trial of hepatic ablation of metastases to modulate and enhance immunotherapy response in non-small cell lung cancer (HAMMER-NSCLC)
    Journal Article

    McMillan, M. T.; Reyngold, M.; Crane, C. H.; O'Brien, D. A. R.; Williams, V. M.; Zinovoy, M.; Cuaron, J. J.; Gönen, M.; Kaiser, A.; Sopka, D. M.; more...
    BMC Cancer (2025)

    Fulltext@MSK | Save
  • Allele-specific HLA LOH in solid tumors: Distinct patterns by tumor type and potential prognostic relevance
    Journal Article

    Sewastianik, T.; Roy, C.; Gormally, M.; Montesion, M.; Halvey, P.; Jindal, A.; Lam, H.; Schoenfeld, A.; Klebanoff, C. A.; Opiteck, G. J.; more...
    Journal for ImmunoTherapy of Cancer (2025)

    Fulltext@MSK | Save
  • Immune checkpoint blockade and transarterial chemoembolization in liver-limited hepatocellular carcinoma: New questions at the dawn of a new era
    Editorial

    Dhyani, A.; Harding, J. J.
    Journal for ImmunoTherapy of Cancer (2025)

    Fulltext@MSK | Save
  • High transposable element expression in sarcomas is associated with increased immune infiltrates and improved outcomes including after immunotherapy
    Journal Article

    Nacev, B. A.; Bradic, M.; Woo, H. J.; Richards, A. L.; Kelly, C. M.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Chi, P.; Movva, S.; more...
    Journal for ImmunoTherapy of Cancer (2025)

    Fulltext@MSK | Save
  • Intraperitoneal CAR T-cell therapy for peritoneal carcinomatosis from gastroesophageal cancer: Preclinical investigations to a phase I clinical trial (NCT06623396)
    Journal Article

    Restle, D.; Amador-Molina, A.; Misawa, K.; Banerjee, S.; Ku, G.; Adusumilli, P. S.
    Journal for ImmunoTherapy of Cancer (2025)

    Fulltext@MSK | Save
  • Phase 1b/2 study evaluating safety, efficacy and immune effects of TLR9 agonist cavrotolimod with anti-PD-1 antibodies among patients with advanced solid tumors
    Journal Article

    Milhem, M. M.; Wise-Draper, T. M.; Chandra, S.; Hanna, G. J.; Laux, D. E.; Medina, T. M.; Ansstas, G.; Daud, A.; Kelly, C. M.; O'Day, S. J.; more...
    Journal for ImmunoTherapy of Cancer (2025)

    Fulltext@MSK | Save
  • Phase II study of rucaparib and nivolumab in patients with leiomyosarcoma
    Journal Article

    Movva, S.; Seier, K.; Bradic, M.; Charalambous, K.; Rosenbaum, E.; Kelly, C. M.; Cohen, S. M.; Hensley, M. L.; Avutu, V.; Banks, L. B.; more...
    Journal for ImmunoTherapy of Cancer (2025)

    Fulltext@MSK | Save
  • The cold immunological landscape of ATM-deficient cancers
    Journal Article

    Sinha, S.; Ng, V.; Novaj, A.; Zhu, Y.; Yazaki, S.; Pei, X.; Derakhshan, F.; Pareja, F.; Setton, J.; Naulin, F.; more...
    Journal for ImmunoTherapy of Cancer (2025)

    Fulltext@MSK | Save
  • Germline prediction of immune checkpoint inhibitor discontinuation for immune-related adverse events
    Journal Article

    Middha, P.; Thummalapalli, R.; Quandt, Z.; Balaratnam, K.; Cardenas, E.; Falcon, C. J.; Princess Margaret Lung Group; Gubens, M. A.; Huntsman, S.; Khan, K.; more...
    Journal for ImmunoTherapy of Cancer (2025)

    Fulltext@MSK | Save
  • Effect of prior and first-line immunotherapy on baseline immune biomarkers and modulation of the tumor microenvironment in response to nivolumab and relatlimab combination therapy in patients with melanoma from RELATIVITY-020
    Journal Article

    Ascierto, P. A.; Tang, H.; Dolfi, S.; Nyakas, M.; Marie Svane, I.; Muñoz-Couselo, E.; Grob, J. J.; Gomez-Roca, C. A.; Chiarion-Sileni, V.; Peltola, K.; more...
    Journal for ImmunoTherapy of Cancer (2025)

    Fulltext@MSK | Save